Michael D. Pak

Array ( [id] => 9850016 [patent_doc_number] => 08951742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof' [patent_app_type] => utility [patent_app_number] => 12/363932 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19487 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12363932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458271 [patent_doc_number] => 20090258423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Cell cycle regulation and differentiation' [patent_app_type] => utility [patent_app_number] => 12/321952 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 32082 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258423.pdf [firstpage_image] =>[orig_patent_app_number] => 12321952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354682 [patent_doc_number] => 20090186026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION' [patent_app_type] => utility [patent_app_number] => 12/354892 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13602 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186026.pdf [firstpage_image] =>[orig_patent_app_number] => 12354892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586769 [patent_doc_number] => 20110281279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'CIRCULATING Epha2 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/808470 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7858 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281279.pdf [firstpage_image] =>[orig_patent_app_number] => 12808470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772195 [patent_doc_number] => 08426147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'RORS as modifiers of the p21 pathway and methods of use' [patent_app_type] => utility [patent_app_number] => 12/325914 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15866 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12325914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6264683 [patent_doc_number] => 20100297615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'EGFR MUTATIONS' [patent_app_type] => utility [patent_app_number] => 12/272321 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8920 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297615.pdf [firstpage_image] =>[orig_patent_app_number] => 12272321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234900 [patent_doc_number] => 20100266604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF TAM RECEPTOR INHIBITORS AS IMMUNOENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS' [patent_app_type] => utility [patent_app_number] => 12/741797 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 43206 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266604.pdf [firstpage_image] =>[orig_patent_app_number] => 12741797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434957 [patent_doc_number] => 20090169543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Method for regulating immune function in primates using the Foxp3 protein' [patent_app_type] => utility [patent_app_number] => 12/291359 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23976 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169543.pdf [firstpage_image] =>[orig_patent_app_number] => 12291359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391237 [patent_doc_number] => 20090208550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Methods and compositions for treating hepatic diseases' [patent_app_type] => utility [patent_app_number] => 12/290021 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20969 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208550.pdf [firstpage_image] =>[orig_patent_app_number] => 12290021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663653 [patent_doc_number] => 20110312922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'EDTA Resistant S100A12 Complexes (ERAC)' [patent_app_type] => utility [patent_app_number] => 12/738579 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19841 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312922.pdf [firstpage_image] =>[orig_patent_app_number] => 12738579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439188 [patent_doc_number] => 20100279314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX' [patent_app_type] => utility [patent_app_number] => 12/738257 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11976 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279314.pdf [firstpage_image] =>[orig_patent_app_number] => 12738257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6347974 [patent_doc_number] => 20100330697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/738337 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16840 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330697.pdf [firstpage_image] =>[orig_patent_app_number] => 12738337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422395 [patent_doc_number] => 20090148850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Methods for identifying modulators of P2RY14' [patent_app_type] => utility [patent_app_number] => 12/286566 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 8326 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148850.pdf [firstpage_image] =>[orig_patent_app_number] => 12286566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6176172 [patent_doc_number] => 20110177611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/675804 [patent_app_country] => US [patent_app_date] => 2008-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11436 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177611.pdf [firstpage_image] =>[orig_patent_app_number] => 12675804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514214 [patent_doc_number] => 20090214520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Soluble CLCA-1 and antagonists to CLCA-1' [patent_app_type] => utility [patent_app_number] => 12/222980 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214520.pdf [firstpage_image] =>[orig_patent_app_number] => 12222980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4554834 [patent_doc_number] => 07820791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'H+-gated ion channel' [patent_app_type] => utility [patent_app_number] => 12/189014 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11282 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820791.pdf [firstpage_image] =>[orig_patent_app_number] => 12189014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508005 [patent_doc_number] => 20090081212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'USE AND TARGETING OF CD98 LIGHT-CHAIN PROTEINS IN THERAPIES FOR THYROID HORMONE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/182030 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21324 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081212.pdf [firstpage_image] =>[orig_patent_app_number] => 12182030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53591 [patent_doc_number] => 07767450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'SLO2 and SLO4, novel potassium channel proteins from human brain' [patent_app_type] => utility [patent_app_number] => 12/177819 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 30356 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767450.pdf [firstpage_image] =>[orig_patent_app_number] => 12177819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608114 [patent_doc_number] => 20100323371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/668220 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 22705 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323371.pdf [firstpage_image] =>[orig_patent_app_number] => 12668220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440930 [patent_doc_number] => 20100104530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'ANTI-VPAC1 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/452356 [patent_app_country] => US [patent_app_date] => 2008-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12507 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104530.pdf [firstpage_image] =>[orig_patent_app_number] => 12452356 [rel_patent_id] =>[rel_patent_doc_number] =>)